Kit S. Lam
47Patents
12h-index
61Co-inventors
84Inventor score
Filing activity: Jan 13, 1983 → Jun 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5840485A | Topologically segregated, encoded solid phase libraries | Chemistry; Metallurgy | 150 | Expired |
| US6090912A | Topologically segregated, encoded solid phase libraries comprising linkers having an enzymatically susceptible bond | Chemistry; Metallurgy | 118 | Expired |
| US5510240A | Method of screening a peptide library | Emerging Cross-Sectional Technologies | 101 | Expired |
| US5650489A | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof | Emerging Cross-Sectional Technologies | 101 | Expired |
| US5858670A | Bio-oligomer libraries and a method of use thereof | Emerging Cross-Sectional Technologies | 83 | Expired |
| US6670142B2 | Method for screening combinatorial bead library, capturing cells from body fluids, and ligands for cancer cells | Physics | 76 | Expired |
| US5635598A | Selectively cleavabe linners based on iminodiacetic acid esters for solid phase peptide synthesis | Chemistry; Metallurgy | 33 | Expired |
| US7262269B2 | Method for screening combinational bead library; ligands for cancer cells | Physics | 29 | Expired |
| US4574116A | Methods and cell lines for immortalization and monoclonal antibody production by antigen-stimulated B-lymphocytes | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5382513A | Method of screening a peptide library | General | 15 | Revoked |
| US7651847B2 | Methods of oligosaccharide profiling for the detection of cancer | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5651943A | Apparatus and method for random polymer synthesis | Chemistry; Metallurgy | 12 | Expired |
| US7576175B2 | Alpha-4 beta-1 integrin ligands for imaging and therapy | Emerging Cross-Sectional Technologies | 12 | Expired |
| US9644038B2 | Apolipoprotein nanodiscs with telodendrimer | Chemistry; Metallurgy | 11 | Active |
| US7632814B2 | HYD1 peptides as anti-cancer agents | Chemistry; Metallurgy | 11 | Active |
| US8895055B2 | Telodendrimer nanodiscs without apolipoprotein | Human Necessities | 9 | Active |
| US8486370B2 | Heterocyclic ligands for integrin imaging and therapy | Emerging Cross-Sectional Technologies | 6 | Active |
| US11053322B2 | Apolipoprotein nanodiscs with telodendrimer | Chemistry; Metallurgy | 6 | Active |
| US10106650B2 | Reversibly crosslinked micelle systems | Emerging Cross-Sectional Technologies | 5 | Active |
| US10406233B2 | Telodendrimers with enhanced drug delivery | Chemistry; Metallurgy | 3 | Active |
| US9119884B2 | LLP2A-bisphosphonate conjugates for osteoporosis treatment | Human Necessities | 3 | Active |
| US11713359B2 | Apolipoprotein nanodiscs with telodendrimer | Chemistry; Metallurgy | 3 | Active |
| US9561256B2 | LLP2A-bisphosphonate conjugates for osteoporosis treatment | Human Necessities | 2 | Active |
| US10238750B2 | Porphyrin modified telodendrimers | Human Necessities | 2 | Active |
| US10556021B2 | Nanocarriers for drug delivery | Performing Operations; Transporting | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.